Recent Updates
Recently added Catalysts
BCRX Positive Sentiment

BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference

Tuesday, January 7, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: BioCryst Pharmaceuticals, Inc. has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 14, 2025, in San Francisco. The presentation will be available via a live audio webcast on the company's website. This event is significant as it allows BioCryst to discuss its latest developments and strategies with a wide audience of investors and industry leaders.
Price reaction · baseline $7.83 (2025-01-06 close) · hit after-hours · 1 other BCRX headline(s) in the window, move may be shared
day 0 close · peak
+4%

Market Sentiment Analysis

POSITIVE FACTORS

  • BioCryst will present at a prestigious conference
  • Opportunity to showcase advancements to investors
  • Potential exposure to industry leaders

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+23%
120-day peak, hindsight
Typical move
2.6%
average across 4 past catalysts
Lead asset
Peramivir
Phase 3 · Influenza

Full Press Release Details

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025, at 6:00 p.m. ET.
Link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals

Frequently Asked Questions

When will BioCryst present at the J.P. Morgan Conference?

BioCryst will present on January 14, 2025, at 6:00 p.m. ET.

Where can I access BioCryst's presentation webcast?

The live audio webcast can be found in the Investors & Media section of their website.

What is BioCryst Pharmaceuticals' stock symbol?

BioCryst Pharmaceuticals is traded under the stock symbol BCRX.

ShareAdd on Google
Tags: BCRX Viatris Investor Conferences Healthcare BioCryst healthcare conference J.P. Morgan investors 2025
Last updated: Jan 7, 2025

Biotech snapshot

Cash runway
$353M liquidity · $0M/mo burn
Low dilution risk
Lead asset
PeramivirPhase 3
Influenza →

Catalyst track record

+23%
best trade around BCRX's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for BCRX.

See every catalyst's timing & PoA →